| Literature DB >> 28541483 |
Nuno Sepúlveda1,2, Alphaxard Manjurano1,3, Susana G Campino1,4, Martha Lemnge5, John Lusingu5, Raimos Olomi3, Kirk A Rockett6, Christina Hubbart6, Anna Jeffreys6, Kate Rowlands6, Taane G Clark1, Eleanor M Riley1, Chris J Drakeley1.
Abstract
Background: Human malaria susceptibility is determined by multiple genetic factors. It is unclear, however, which genetic variants remain important over time.Entities:
Keywords: Malaria; SNP; genetic association; transmission intensity
Mesh:
Substances:
Year: 2017 PMID: 28541483 PMCID: PMC5853769 DOI: 10.1093/infdis/jix250
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226
Figure 1.Map of study sites and the corresponding transects: Rombo (transect 1), North Pare (transect 2), South Pare (transect 3), West Usambara 1 (transect 4), West Usambara 2 (transect 5), and West Usambara 3 (transect 6). Locations of 8 meteorological stations are also shown (asterisks).
Baseline Information on Different Malaria Transmission Measures for the 24 Villages Considered in the Study
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
|
| ||
| Kilimanjaro region | |||||
| Rombo (Wachaga, 80%) | |||||
| Mokala (413) | 1702 (1623–1788) | 20.7 | 0.027 | 4.4 | 5.6 |
| Machame Aleni (249) | 1421 (1380–1482) | 26.2 | 0.038 | 1.3 | 0.9 |
| Ikuini (363) | 1160 (1118–1215) | 24.2 | 0.033 | 12.3 | 11.0 |
| Kileo (247) | 723 (721–724) | 78.6 | 0.343 | 6.6 | 8.6 |
| North Pare (Wapare, 92%) | |||||
| Kilomeni (351) | 1556 (1384–1745) | 36.1 | 0.044 | 3.4 | 1.0 |
| Lambo (295) | 1187 (1146–1231) | 62.7 | 0.147 | 2.5 | 3.9 |
| Ngulu (405) | 831 (798–863) | 93.4 | 0.765 | 6.2 | 8.5 |
| Kambi ya Simba (281) | 745 (716–767) | 90.9 | 0.626 | 10.1 | 13.8 |
| South Pare (Wapare, 90%) | |||||
| Bwambo (422) | 1598 (1564–1643) | 25.5 | 0.033 | 3.5 | 3.4 |
| Mpinji (386) | 1445 (1307–1667) | 35.3 | 0.054 | 2.8 | 3.2 |
| Goha (408) | 1162 (1079–1228) | 59.8 | 0.144 | 11.4 | 14.2 |
| Kadando (414) | 528 (525–531) | 79.7 | 0.333 | 23.4 | 28.3 |
| Tanga region | |||||
| West, Usambara 1 (Wasambaa, 88%) | |||||
| Emmao (199) | 1845 (1810–1872) | 17.3 | 0.019 | 3.7 | 0.0 |
| Handei (417) | 1425 (1372–1517) | 68.1 | 0.209 | 27.9 | 32.1 |
| Tewe (372) | 1049 (965–1126) | 69.9 | 0.205 | 34.4 | 35.2 |
| Mng’alo (398) | 416 (406–455) | 90.9 | 0.802 | 49.2 | 69.3 |
| West, Usamabara 2 (Wasambaa, 88%) | |||||
| Kwadoe (435) | 1523 (1473–1603) | 41.6 | 0.073 | 8.5 | 6.5 |
| Funta (315) | 1279 (1236–1322) | 73.7 | 0.268 | 24.7 | 27.6 |
| Tamota (417) | 1176 (1073–1338) | 59.3 | 0.140 | 24.7 | 24.8 |
| Mgila (391) | 432 (406–455) | 86.5 | 0.543 | 41.4 | 55.6 |
| West, Usambara 3 (Wasambaa, 65%) | |||||
| Magamba (237) | 1685 (1659–1751) | 39.4c | 0.048c | 3.2 | 1.0 |
| Ubiri (194) | 1216 (1174–1262) | 47.0c | 0.052c | 16.2 | 14.8 |
| Kwemasimba (247) | 662 (636–691) | 64.7c | 0.103c | 25.3 | 32.4 |
| Mgome (240) | 196 (165–208) | 96.5 | 0.941 | 40.2 | 69.0 |
Abbreviation: SCR, seroconversion rate.
aThe major ethnic group and its respective percentage is given parenthetically after each transect name.
bSCR was defined as the yearly average frequency at which seronegative individuals became seropositive.
cEstimates based on data imputation performed using MICE software.
Significant Genetic Associations Between Malaria Transmission Measures and Autosomal SNPs Using −log10(P value) as an Association Measure With a Cutoff of 2a
|
|
|
|
|
|
| − |
| |
|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
| Altitude | ||||||||
| rs11575518 | 7 | 50535681 |
| G/A | Log | 2.00 | 0.821 (0.551)b | −0.166 (0.087)b |
| rs3211938 | 7 | 80300449 |
| T/G | Log | 3.73 | 0.575 (0.153)b,c | NA |
| rs334 | 11 | 5248232 |
| A/T | Linear | 4.33 | 0.162 (0.032)b,c | NA |
| α-Thalassemiad | 16 | 222500 |
| α+/α− | Linear | 3.28 | 0.078 (0.015)b | −0.105 (0.153)b |
| α-Thalassemiae | 16 | 222500 |
| α+/α− | Linear | 5.30 | 0.081 (0.019)b | −0.071 (0.027)b |
| SCR | ||||||||
| rs3211938 | 7 | 80300449 |
| T/G | Log | 2.59 | −0.241 (0.084)c | NA |
| rs334 | 11 | 5248232 |
| A/T | Log | 3.48 | −0.591 (0.151)c | NA |
| α-Thalassemiad | 16 | 222500 |
| α+/α− | Log | 5.58 | −0.337 (0.086) | 0.443 (0.709) |
| α-Thalassemiae | 16 | 222500 |
| α+/α− | Linear | 5.30 | −0.315 (0.081) | 0.294 (0.113) |
| Parasite rate | ||||||||
| rs31481 | 5 | 131397202 |
| G/A | Log odds | 2.14 | −0.097 (0.032) | −0.091 (0.116) |
| rs3900945 | 5 | 131592870 |
| C/T | Log odds | 2.49 | −0.073 (0.047) | 0.003 (0.091) |
| rs10463891 | 5 | 131597392 |
| G/A | Log odds | 2.65 | −0.080 (0.046) | −0.031 (0.082) |
| rs2069744 | 5 | 131994669 |
| C/T | Log odds | 2.20 | −0.025 (0.043) | 0.017 (0.052) |
| rs2242665 | 6 | 31839309 |
| G/A | Log odds | 2.04 | −0.080 (0.072) | 0.038 (0.049) |
| rs11983581 | 7 | 50532888 |
| A/T | Log odds | 2.54 | 0.470 (0.309) | 0.079 (0.053) |
| rs11982772 | 7 | 50533062 |
| A/C | Log odds | 2.84 | 0.077 (0.047) | 0.467 (0.310) |
| rs11575527 | 7 | 50534327 |
| G/C | Log odds | 2.59 | 0.084 (0.053) | 0.485 (0.308) |
| rs11575522 | 7 | 50535395 |
| C/T | Log odds | 2.63 | 0.076 (0.051) | 0.476 (0.305) |
| rs11575518 | 7 | 50535681 |
| G/A | Log odds | 2.83 | 0.483 (0.308) | 0.083 (0.050) |
| rs3211938 | 7 | 80300449 |
| T/G | Log odds | 3.19 | −0.235 (0.102)c | NA |
| rs334 | 11 | 5248232 |
| A/T | Log odds | 2.61 | −0.610 (0.181)c | NA |
| α-Thalassemiad | 16 | 222500 |
| Α+/α− | Log odds | 3.39 | −0.390 (0.081) | 1.098 (0.678) |
| α-Thalassemiae | 16 | 222500 |
| Α+/α− | Log odds | 5.78 | −0.377 (0.086) | 0.288 (0.133) |
Abbreviations: Chr, chromosome; NA, not applicable; SCR, seroconversion rate; SE, standard error; SNP, single-nucleotide polymorphism.
aSNPs were deemed significant if −log10(P value) was >2.
bEstimates per 100-m increase in altitude.
cEstimates based on log fAA/(fAB+ fBB).
dResults based on complete data (13 villages).
eResults based on data imputation performed using MICE software.
Significant Genetic Associations Between Malaria Transmission Measures and X-linked G6PD SNPs Using −Log10(P value) as an Association Measure With a Cutoff of 2a
|
|
|
|
| − |
| ||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| Altitude, female participants | |||||||
| rs28470352 | 153753490 | T/A | Linear | 3.18 | 0.023 (0.006) | −0.008 (0.031) | NA |
| rs5986990 | 153761628 | G/A | Linear | 3.36 | 0.022 (0.006) | −0.007 (0.031) | NA |
| rs2515905 | 153762075 | G/A | Log | 2.51 | 0.214 (0.075) | 0.379 (0.647) | NA |
| rs2515904 | 153762771 | G/C | Log | 2.76 | 0.204 (0.059) | 0.245 (0.651) | NA |
| rs1050829 | 153763492 | T/C | Linear | 2.16 | 0.018 (0.007) | −0.009 (0.033) | NA |
| rs762516 | 153764663 | C/T | Log | 2.61 | 0.201 (0.061) | 0.251 (0.638) | NA |
| Altitude, male participants | |||||||
| rs1050829 | 153763492 | T/C | Linear | 2.05 | NA | NA | 0.027 (0.010) |
| SCR, female participantsb | |||||||
| rs28470352 | 153753490 | T/A | Log | 2.33 | −0.069 (0.030) | −0.064 (0.128) | NA |
| rs5986990 | 153761628 | G/A | Log | 2.53 | −0.062 (0.029) | −0.095 (0.127) | NA |
| rs2515905 | 153762075 | G/A | Linear | 2.12 | −0.345 (0.176) | −0.939 (1.372) | NA |
| rs2515904 | 153762771 | G/C | Linear | 3.22 | −0.430 (0.128) | −0.685 (1.380) | NA |
| rs1050828 | 153764217 | C/T | Linear | 2.85 | −0.591 (0.195) | −0.603 (1.136) | NA |
| rs762516 | 153764663 | C/T | Linear | 3.00 | −0.422 (0.133) | −0.612 (1.354) | NA |
| SCR, male participantsb | |||||||
| rs1050828 | 153764217 | C/T | Log | 3.24 | NA | NA | −0.114 (0.050) |
| Parasite rate, female participants | |||||||
| rs28470352 | 153753490 | T/A | Log odds | 5.04 | −0.109 (0.029) | 0.211 (0.135) | NA |
| rs2230037 | 153760654 | G/A | Log odds | 2.43 | 0.170 (0.052) | 0.019 (0.061) | NA |
| rs5986990 | 153761628 | G/A | Log odds | 5.17 | −0.104 (0.027) | 0.154 (0.139) | NA |
| rs2515905 | 153762075 | G/A | Log odds | 2.57 | −0.107 (0.044) | 0.231 (0.363) | NA |
| rs2515904 | 153762771 | G/C | Log odds | 4.14 | −0.113 (0.034) | 0.288 (0.360) | NA |
| rs1050829 | 153763492 | T/C | Log odds | 4.66 | −0.097 (0.030) | 0.221 (0.141) | NA |
| rs1050828 | 153764217 | C/T | Log odds | 3.88 | −0.070 (0.062) | 0.379 (0.288) | NA |
| rs762516 | 153764663 | C/T | Log odds | 3.84 | −0.112 (0.035) | 0.289 (0.353) | NA |
| Parasite rate, male participants | |||||||
| rs28470352 | 153753490 | T/A | Log odds | 2.96 | NA | NA | 0.148 (0.051) |
| rs1050829 | 153763492 | T/C | Log odds | 4.56 | NA | NA | 0.143 (0.036) |
| rs1050828 | 153764217 | C/T | Log odds | 4.35 | NA | NA | 0.125 (0.059) |
| rs762516 | 153764663 | C/T | Log odds | 3.12 | NA | NA | 0.164 (0.060) |
Abbreviations: NA, not applicable; SCR, seroconversion rate; SE, standard error; SNP, single-nucleotide polymorphism.
aSNPs were deemed significant if −log10(P value) was >2.
bResults based on data imputation performed using MICE software.
Figure 2.Association between single-nucleotide polymorphisms (SNPs) and 2 principal components generated from summary data of the 3 malaria transmission measures for each village. A, Association of autosomal SNPs and each principal component. B, Association of X-linked SNPs and each principal component. Dashed lines represent the cutoff set for significant association. Specifically, a given genetic association was deemed significant for SNPs when the −log10(P value) was >2 (ie, P < .01).
Detected Associations Between the SNPs and the First 2 PCs Using A Statistically Significant Cutoff of 2 for −log10(P value)
|
|
|
|
|
| − |
| ||
|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||
| 1st PC, overall | ||||||||
| rs3900945 | 5 | 131592870 |
| C/T | 2.25 | −0.063 (0.030) | 0.040 (0.065) | NA |
| rs10463891 | 5 | 131597392 |
| G/A | 2.03 | −0.061 (0.030) | 0.019 (0.055) | NA |
| rs11982772 | 7 | 50533062 |
| G/A | 2.03 | −0.049 (0.032) | 0.317 (0.207) | NA |
| rs11575518 | 7 | 50535681 |
| G/A | 2.18 | 0.326 (0.206) | 0.054 (0.034) | NA |
| rs3211938 | 7 | 80300449 |
| T/G | 3.30 | −0.189 (0.063)a | NA | NA |
| rs334 | 11 | 5248232 |
| A/T | 4.12 | −0.485 (0.102)a | NA | NA |
| α-Thalassemia | 16 | 222500 |
| α+/α− | 7.12 | −0.262 (0.056) | 0.226 (0.085) | NA |
| 1st PC, female participants | ||||||||
| rs28470352 | X | 153753490 |
| T/A | 3.88 | −0.069 (0.020) | 0.034 (0.097) | NA |
| rs5986990 | X | 153761628 |
| G/A | 4.12 | −0.064 (0.019) | 0.012 (0.097) | NA |
| rs2515905 | X | 153762075 |
| G/A | 2.39 | −0.067 (0.030) | −0.128 (0.244) | NA |
| rs2515904 | X | 153762771 |
| G/C | 3.53 | −0.074 (0.023) | −0.089 (0.245) | NA |
| rs1050829 | X | 153763492 |
| T/C | 3.01 | −0.056 (0.022) | 0.037 (0.101) | NA |
| rs1050828 | X | 153764217 |
| C/T | 2.61 | −0.063 (0.040) | 0.012 (0.203) | NA |
| rs762516 | X | 153764663 |
| C/T | 3.29 | −0.072 (0.024) | −0.086 (0.240) | NA |
| 1st PC, male participants | ||||||||
| rs28470352 | X | 153753490 |
| T/A | 2.30 | NA | NA | −0.0812 (0.0370) |
| rs1050829 | X | 153763492 |
| T/C | 3.08 | NA | NA | −0.0766 (0.0283) |
| rs1050828 | X | 153764217 |
| C/T | 3.50 | NA | NA | −0.0838 (0.0392) |
| 2nd PC, overall | ||||||||
| rs17047660 | 1 | 207782856 |
| A/G | 2.04 | 0.135 (0.095) | 0.027 (0.219) | NA |
| rs35415145 | 5 | 131396406 |
| C/T | 2.24 | 0.070 (0.229)a | NA | NA |
| rs272893 | 5 | 131663062 |
| A/G | 2.75 | −0.214 (0.235) | −0.098 (0.073) | NA |
| rs4526098 | 5 | 131892979 |
| G/A | 2.03 | −0.225 (0.133) | 0.026 (0.121) | NA |
| rs2069744 | 5 | 131994669 |
| C/T | 2.18 | −0.085 (0.111) | −0.133 (0.127) | NA |
| rs361525 | 6 | 31543101 |
| G/A | 2.86 | 0.258 (0.155) | −0.482 (0.903) | NA |
| rs3093662 | 6 | 31544189 |
| A/G | 2.95 | 0.138 (0.128) | −0.672 (0.476) | NA |
| rs4986790 | 9 | 120475302 |
| A/G | 2.01 | 0.285 (0.186) | 1.277 (1.432) | NA |
| 2nd PC, female participants | ||||||||
| rs28470352 | X | 153753490 |
| T/A | 2.22 | −0.046 (0.098) | 0.983 (0.266) | NA |
| rs5986990 | X | 153761628 |
| G/A | 2.04 | −0.056 (0.091) | 0.893 (0.289) | NA |
| rs2515904 | X | 153762771 |
| G/C | 2.06 | −0.005 (0.109) | 2.484 (0.706) | NA |
| rs1050829 | X | 153763492 |
| T/C | 2.66 | −0.084 (0.093) | 1.011 (0.283) | NA |
| rs1050828 | X | 153764217 |
| C/T | 2.21 | 0.177 (0.156) | 2.119 (0.571) | NA |
| rs762516 | X | 153764663 |
| C/T | 2.11 | −0.018 (0.110) | 2.434 (0.699) | NA |
Abbreviations: Chr, chromosome; NA, not applicable; PC, principal component; SE, standard error; SNP, single-nucleotide polymorphism.
aEstimates based on log fAA/(fAB+fBB).